IP Library Granted Patent US 8,915,943
Granted Patent B2
US 8,915,943 · App. 12/062,214 · Granted Dec 23, 2014

Self-retaining systems for surgical procedures

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,915,943
App. No.
12/062,214
Granted
Dec 23, 2014
Kind
B2
Abstract

The present invention relates generally to self-retaining systems for surgical procedures, methods of manufacturing self-retaining systems for surgical procedures, and their uses.

Claims (32)

1. A self-retaining suture that can be inserted into tissue comprising:

an elongated suture body having a first end and a second end;

a plurality of primary retainers extending from said suture body and with the primary retainers having a primary tissue penetrating end and with the primary tissue penetrating end pointing away from the first end;

each of said primary retainers including an inner retainer surface that substantially faces the suture body and an outer surface facing substantially away from the suture body, where the outer surface is configured so as to avoid catching or grabbing tissue during deployment of the suture;

each of said primary retainers including a secondary retainer with a secondary tissue penetrating end, which secondary retainer extends from the inner retainer surface, and which secondary tissue penetrating end pointed toward said first end, such that during deployment of the suture into tissue with the first end entering the tissue first in a first deployment direction, the secondary retainer is shielded between the suture body and the primary retainer so as not to engage the tissue and such that when the suture is deployed in a direction opposite the first deployment direction, the secondary retainer can engage the tissue.

2. The suture of claim 1 wherein the secondary retainer extends from the primary tissue penetrating end of said primary retainer.

3. The suture of claim 1 including a plurality of secondary retainers extending from the inner retainer surface of the primary retainers.

4. The suture of claim 1 including a plurality of secondary retainers extending from the inner retainer surfaces of the primary retainers, with each secondary retainer including a secondary tissue penetrating end that pointed toward said first end.

5. The suture of claim 1 wherein said secondary retainer is formed from material that initially defined the primary retainer.

6. The suture of claim 1 wherein said secondary retainer is cut from said primary retainer.

7. The suture of claim 1 wherein said secondary retainer is formed at least in part from the inner retainer surface.

8. The suture of claim 1 including another plurality of secondary retainers extending from said suture body.

9. The suture of claim 1 including another plurality of secondary retainers extending from said suture body, which each said secondary retainers including a secondary tissue penetrating end, which each secondary tissue penetrating end directed away from the first end.

10. The suture of claim 1 wherein said suture body includes a transition segment located between said first end and said second end, and wherein said transition segment includes a transition segment diameter and said first end includes a first end diameter and said second end includes a second end diameter, and wherein said transition segment diameter is larger than at least one of said first end diameter and said second end diameter such that said transition segment diameter can increase tissue hold due to the transition segment being urged into a tract created by a smaller diameter created by one of said first end diameter and said second end diameter.

11. The suture of claim 1 including a coating and wherein said coating comprises at least one composition selected from anti-proliferative agents, anti-angiogenic agents, anti-infective agents, fibrosis-inducing agents, anti-scarring agents, lubricious agents, echogenic agents, anti-inflammatory agents, cell cycle inhibitors, analgesics, and anti-microtubule agents.

12. A self-retaining suture that can be inserted into tissue comprising:

an elongated suture body having a first end and a second end;

a plurality of primary retainers extending from said suture body and with the primary retainers having a primary tissue penetrating end and with the primary tissue penetrating end pointing away from the first end;

each of said primary retainers include an inner retainer surface that substantially faces the suture body and an outer surface facing substantially away from the suture body, where the outer surface is configured so as to avoid catching or grabbing tissue during deployment of the suture;

a secondary retainer which is filamentary and said secondary retainer extending from the inner retainer surface, such that during deployment of the suture into tissue with the first end entering the tissue first in a first deployment direction, the secondary retainer is shielded between the suture body and the primary retainer.

13. The suture of claim 12 wherein said filamentary second retainers are created on the primary retainer by polymer grafting.

14. The suture of claim 12 wherein said filamentary second retainers are created on the primary retainer by polymer chains grown off of the primary retainer.

15. The suture of claim 12 wherein said filamentary second retainers increase the microscopic surface area of the primary retainers and are adapted for tissue engagement.

16. A self-retaining suture that can be inserted into tissue comprising:

an elongated suture body having a first end and a second end;

a plurality of primary retainers extending from said suture body and with the primary retainers having a primary tissue penetrating end and with the primary tissue penetrating end pointing away from the first end and each primary retainer having an outer surface facing substantially away from the suture body, the outer surface being configured so as to avoid catching or grabbing tissue during deployment of the suture; and

a secondary retainer with a secondary tissue penetrating end, which secondary retainer extends from the primary retainer, and which secondary tissue penetrating end pointed toward said first end.

17. The suture of claim 16 wherein said secondary retainer is formed from material that initially defined the primary retainer.

18. The suture of claim 16 wherein said secondary retainer is cut from said primary retainer.

19. The suture of claim 16 wherein said secondary retainer is formed at least in part from an inner retainer surface of said primary retainer.

20. The suture of claim 16 including another plurality of secondary retainers extending from said suture body.

21. The suture of claim 16 wherein said suture body includes a transition segment located between said first end and said second end, and wherein said transition segment includes a transition segment diameter and said first end includes a first end diameter and said second end includes a second end diameter and wherein said transition segment diameter is larger than at least one of said first end diameter and said second end diameter such that said transition segment diameter can increase tissue hold due to the transition segment being urged into a tract created by a smaller diameter created by one of said first end diameter and said second end diameter.

Assignments (11)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 6, 2021
From: ETHICON LLC
To: CILAG GMBH INTERNATIONAL
Reel/Frame 056983/0569 →
RELEASE OF SECURITY INTEREST : RECORDED AT REEL/FRAME - 049288/0184 Recorded Jan 29, 2021
From: CAPITAL ONE, NATIONAL ASSOCIATION
To: ANGIOTECH PHARMACEUTICALS, INC.
Reel/Frame 055171/0634 →
SECURITY INTEREST Recorded May 26, 2019
From: ANGIOTECH PHARMACEUTICALS, INC.
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 049288/0184 →
RELEASE OF SECURITY INTEREST Recorded Apr 12, 2013
From: WELLS FARGO CAPITAL FINANCE, LLC
To: ANGIOTECH PHARMACEUTICALS, INC.; AMERICAN MEDICAL INSTRUMENTS HOLDINGS, INC.; ANGIOTECH AMERICA, INC.; ANGIOTECH BIOCOATINGS CORP.; ANGIOTECH PHARMACEUTICALS (US), INC.; B.G. SULZLE, INC.; MANAN MEDICAL PRODUCTS, INC.; MEDICAL DEVICE TECHNOLOGIES, INC.; QUILL MEDICAL, INC.; SURGICAL SPECIALTIES CORPORATION; ANGIOTECH INTERNATIONAL HOLDINGS CORP.
Reel/Frame 030211/0479 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 27, 2012
From: ANGIOTECH PHARMACEUTICALS, INC.; QUILL MEDICAL, INC.
To: ETHICON, INC.; ETHICON, LLC
Reel/Frame 029294/0443 →
PARTIAL RELEASE OF SECURITY INTERESTS - PATENTS (US) Recorded May 16, 2012
From: WELLS FARGO CAPITAL FINANCE, LLC
To: QUILL MEDICAL, INC.; ANGIOTECH PHARMACEUTICALS, INC.
Reel/Frame 028216/0499 →
PARTIAL RELEASE OF SECURITY INTERESTS - PATENTS (US) Recorded Apr 20, 2012
From: DEUTSCHE BANK NATIONAL TRUST COMPANY
To: QUILL MEDICAL, INC.; ANGIOTECH PHARMACEUTICALS, INC.
Reel/Frame 028078/0699 →
PARTIAL RELEASE OF SECURITY INTEREST - PATENTS Recorded Apr 10, 2012
From: WELLS FARGO CAPITAL FINANCE, LLC
To: QUILL MEDICAL, INC.; ANGIOTECH PHARMACEUTICALS, INC.
Reel/Frame 028022/0861 →
PATENT SECURITY AGREEMENT Recorded May 13, 2011
From: ANGIOTECH PHARMACEUTICALS, INC.; AFMEDICA, INC.; AMERICAN MEDICAL INSTRUMENTS HOLDINGS, INC.; ANGIOTECH AMERICA, INC.; ANGIOTECH BIOCOATINGS CORP.; ANGIOTECH DELAWARE, INC.; ANGIOTECH FLORIDA HOLDINGS, INC.; ANGIOTECH PHARMACEUTICALS (US), INC.; B.G. SULZLE, INC.; MANAN MEDICAL PRODUCTS, INC.; MEDICAL DEVICE TECHNOLOGIES, INC.; NEUCOLL INC.; QUILL MEDICAL, INC.; SURGICAL SPECIALTIES CORPORATION; 0741693 BRITISH COLUMBIA LTD.; ANGIOTECH INTERNATIONAL HOLDINGS, CORP.
To: WELLS FARGO CAPITAL FINANCE, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 026275/0507 →
SECURITY AGREEMENT Recorded Mar 2, 2009
From: ANGIOTECH PHARMACEUTICALS, INC.; AFMEDICA, INC.; AMERICAN MEDICAL INSTRUMENTS HOLDINGS, INC.; ANGIOTECH AMERICA, INC.; ANGIOTECH BIOCOATINGS CORP.; ANGIOTECH CAPITAL, LLC; ANGIOTECH PHARMACEUTICALS (US), INC.; B.G. SULZLE, INC.; CRIMSON CARDINAL CAPITAL, LLC; MANAN MEDICAL PRODUCTS, INC.; MEDICAL DEVICE TECHNOLOGIES, INC.; NEUCOLL INC.; QUILL MEDICAL, INC.; SURGICAL SPECIALTIES CORPORATION; 0741693 BRITISH COLUMBIA LTD.; 3091796 NOVA SCOTIA COMPANY; ANGIOTECH INTERNATIONAL HOLDINGS, CORP.; ANGIOTECH INVESTMENT PARTNERSHIP
To: WELLS FARGO FOOTHILL, LLC AS AGENT
Reel/Frame 022329/0310 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 24, 2008
From: HUNTER, WILLIAM L.
To: ANGIOTECH PHARMACEUTICALS, INC.
Reel/Frame 021142/0809 →